CBDL.US Cbd Life Sciences Inc
- Market cap
- USD 611K
- P/E
- -
- P/B
- 10.06x
- ROE
- -7.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CBDL.US undervalued?
Graham numberThe Graham number of Cbd Life Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cbd Life Sciences Inc fundamental analysis
No fundamental analysis for Cbd Life Sciences Inc yet.
Cbd Life Sciences Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cbd Life Sciences Inc
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include such as hemp drops, recovery pain relief products, anxiety and sleep solutions, supplements, edibles, bath products, kosher products, and a full line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 20…
Full company profileCbd Life Sciences Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cbd Life Sciences Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 2.57M | 528K | 79.6K | 226K | 59.3K | 160K | 167K | 109K | 98.3K | 82.9K |
| Gross Profit | -8.69K | 2.56M | 528K | 36.6K | -212K | -148K | -280K | -30.6K | -9.89K | 41.5K | 48.8K |
| Operating Income | -85.2K | 1.80M | -470K | -870K | -384K | -5.13M | -860K | -78.6K | -757K | -102K | -41.8K |
| EBITDA | -76.5K | 1.83M | -394K | -786K | -1.24M | 1.01M | -806K | -23.0K | -702K | -102K | -41.8K |
| Net Income | -82.9K | 1.24M | -2.92M | -861K | -1.69M | -5.13M | -860K | -78.6K | -757K | -48.9K | -41.3K |
| EPS | -6,577 | 3,060 | -552 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 610K | 2.66M | 189K | 1.49M | 144K | 1.36M | 473K | 419K | 407K | 805K | 518K |
| Total Liabilities | 481K | 294K | 165K | 460K | 164K | 30.4K | 169K | 24.7K | 14.1K | 38.5K | -40.2K |
| Shareholders' Equity | 128K | 2.37M | 24.7K | 1.03M | -20.4K | 1.33M | 473K | 395K | 393K | 767K | 558K |
| Cash & Short-term Investments | - | 1.79K | 245.00 | 29.0K | 11.0K | 1.03M | 558.00 | 2.52K | 6.55K | 332K | 473K |
| Total Debt | 277K | 211K | 102K | 160K | - | - | - | - | - | - | -6.77K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -70.2K | 2.90M | -3.05M | -1.84M | -501K | -5.15M | -804K | -16.6K | -583K | -139K | 181K |
| Capital Expenditure | 3.00 | 2.94K | 152K | 152K | 3.00 | 162K | 69.0K | 0.00 | 3.00 | 0.00 | 9.51K |
| Free Cash Flow | -70.3K | 2.90M | -3.05M | -1.84M | -501K | -5.31M | -1.03M | 1.96K | -583K | -139K | 171K |
| Ratios | |||||||||||
| ROE | -64.7% | 52.4% | -11,835.1% | -83.5% | - | -384.7% | -181.7% | -19.9% | -192.9% | -6.4% | -7.4% |
| ROA | -13.6% | 46.6% | -1,544.6% | -57.7% | -1,179.0% | -376.1% | -181.7% | -18.7% | -186.2% | -6.1% | -8.0% |
| Net Profit Margin | - | 48.4% | -553.6% | -1,081.2% | -750.1% | -8,654.2% | -536.6% | -47.0% | -695.4% | -49.8% | -49.8% |
| Debt to Equity | 2.16x | 0.09x | 4.12x | 0.16x | - | - | - | - | - | - | -0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cbd Life Sciences Inc dividends
Cbd Life Sciences Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:300 on Apr 22, 2024.
Who owns Cbd Life Sciences Inc
Ownership data of Cbd Life Sciences Inc is not available yet.
Cbd Life Sciences Inc company profile
- Company name
- Cbd Life Sciences Inc
- Ticker
- CBDL.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 3
- Fiscal year end
- December
- Address
- 10953 N. Frank Lloyd Wright Boulevard, Scottsdale, AZ, United States, 85259
- Phone
- 480-209-1720
- Website
- thecbdvault.com
About Cbd Life Sciences Inc
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include such as hemp drops, recovery pain relief products, anxiety and sleep solutions, supplements, edibles, bath products, kosher products, and a full line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.
Cbd Life Sciences Inc management
3- Ms. Lisa Anne NelsonCEO, President, CFO, Secretary, Treasurer & Director · born 1967
- Mr. Matthew McGeeChief Marketing Officer · born 1999
- Ms. Brianna NelsonChief Product Developer & Director · born 1997